Michael Staehler
Department of Urology
University of Munich
Klinikum Grosshadern
Marchioninistr. 15
Germany
Name/email consistency: high
- Sorafenib after Combination Therapy with Gemcitabine plus Doxorubicine in Patients with Sarcomatoid Renal Cell Carcinoma: A Prospective Evaluation. Staehler, M., Haseke, N., Roosen, A., Stadler, T., Bader, M., Siebels, M., Karl, A., Stief, C.G. Eur. J. Med. Res. (2010)
- Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. Staehler, M.D., Kruse, J., Haseke, N., Stadler, T., Roosen, A., Karl, A., Stief, C.G., Jauch, K.W., Bruns, C.J. World. J. Urol (2010)
- The growth rate of large renal masses opposes active surveillance. Staehler, M., Haseke, N., Stadler, T., Zilinberg, E., Nordhaus, C., Nuhn, P., Khoder, W.Y., Karl, A., Stief, C.G. BJU Int. (2010)
- Complete remission achieved with angiogenic therapy in metastatic renal cell carcinoma including surgical intervention. Staehler, M., Haseke, N., Zilinberg, E., Stadler, T., Karl, A., Siebels, M., Dürr, H.R., Siegert, S., Jauch, K.W., Bruns, C.J., Stief, C.G. Urol. Oncol. (2010)
- Plasma N-terminal pro-brain natriuretic peptide as prognostic marker in fatal cardial decompensation with sunitinib malate therapy. Staehler, M., Haseke, N., Zilinberg, K., Stadler, T., Stief, C.G. Urol. Int. (2010)
- Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase inhibition with sunitinib. Staehler, M., Schöppler, G., Haseke, N., Stadler, T., Karl, A., Siebels, M., Ihrler, S., Stief, C.G. Clin. Genitourin. Cancer (2009)
- Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase-inhibition with sunitinib. Staehler, M., Haseke, N., Schöppler, G., Stadler, T., Karl, A., Siebels, M., Ihrler, S., Stief, C.G. Eur. J. Med. Res. (2008)
- Editorial Comment on: Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Staehler, M. Eur. Urol. (2007)
- Targeted agents for the treatment of advanced renal cell carcinoma. Staehler, M., Rohrmann, K., Haseke, N., Stief, C.G., Siebels, M. Curr. Drug. Targets (2005)